As I write my final column as Editor-in-Chief, I am filled with both gratitude and optimism. Serving in this role has been a profound privilege, offering me the opportunity to elevate my voice and share the groundbreaking advancements in oncology that are transforming patient care and outcomes.

Over the past 2 years, we have explored pivotal trends shaping our field, from the integration of artificial intelligence into clinical workflows to the rise of precision medicine and making continued progress for equitable access to care. These developments are not just reshaping how we care for patients with cancer—they are redefining what is possible for patients, families, and caregivers. Reflecting on these themes, I am reminded of the incredible resilience and innovation within our oncology community, particularly recovering from the challenges of a global pandemic, including workforce shortages, supply chain challenges, and clinician and staff burnout, just to name a few.

Looking ahead, the future of cancer care will be driven by those who are unafraid to challenge the status quo and unleash transformative change while navigating uncertainty. It will require us to think outside of the box, innovate responsibly, and maintain our unwavering commitment to the patients we serve. While my time as Editor-In-Chief is now at an end, I am confident that the dialogue we have cultivated here will continue to inspire action and innovation.

Be a part of these critical conversations by applying today for a 2025 ACCC Innovator Award. Now in its 15th year, these prestigious awards recognize visionary and compelling ideas in oncology from ACCC Cancer Program Members nationwide. The ACCC Innovator Awards shine a national spotlight on solutions in practice today that advance access, quality, and value in cancer care delivery. Mount Sinai has been awarded 2 ACCC Innovator Awards: the first in 2018 for work done by its dedicated palliative radiotherapy team and the second in 2023 for the creation of an advanced practice radiation therapist role, so I can personally attest that the experience is a rewarding one. So, do not miss this opportunity to showcase your cancer program on a national stage, to unleash the power of positive change, and to inspire others to think differently about cancer care delivery and the patient experience. Apply online today at innovator.awardsplatform.com. ACCC is accepting applications through February 24, 2025.

In closing, I would like to thank you for allowing me to be part of this journey. I encourage all of you to stay engaged, curious, and collaborative as we work together to shape the next era of cancer care. As always, I look forward to seeing you in person at the ACCC 51st Annual Meeting & Cancer Center Business Summit, March 5-7, in Washington, DC, and at the ACCC 42nd National Oncology Conference, October 15-17, in Denver, Colorado, where we will learn from and celebrate the 2025 ACCC Innovator Award winners.